Business

CCM Research Issues Technical Research Report on Biorem Inc.

CCM Research Issues Technical Research Report on Biorem Inc.

articleBiorem Inc.March 2, 20093/company/biorem-inc/news/ccm-research-issues-technical-research-report-on-biorem-inc
CCM Research Issues Technical Research Report on Biorem Inc.

About this update from Biorem Inc.

[{"type":"text","content":"CCM Research Issues Technical Research Report on Biorem Inc.\n\n\n\nCCM Research Issues Technical Research Report on Biorem Inc.\n\nCCM Research has written a Technical Research Report on Biorem Inc.\n\nToronto, Ontario CANADA, March 02, 2009 /FSC/ - Biorem Inc. (BRM - TSX Venture), manufactures Biosorbens(r) biofilter media and is a leading supplier of biofilters and biotrickling for air pollution control in municipal and industrial applications, including BIOCUBE(r) modular units and Mytilus(r) biotrickling filters. With over 600 installed systems and over a decade of experience, the Company's products are the technology of choice for odor control at wastewater treatment plants across North America. Additional information on BIOREM(r) is also available at www.biorem.biz. \n\nTechnical Reports are designed for those investors who consult technical analysis for their investing/trading decisions.  Technical investors account for a large percentage of total investors, especially in the small cap market.  This type of analytical data gives investors an idea of market psychology regarding the stock by way of moving averages vis-a-vis stock price and sentiment. It provides investors with relevant price points for their buy/sell decisions - resist/support.  Technical Reports also state whether or not a company is a value, neutral, or momentum investment - based on the level of overbuying or overselling.\n\nThe Technical Report on Biorem explains the following:\n\n\"BRM is currently trading at an all time low of $0.44.   Overhead resistance remains at $1.00.  BRM is extremely OVERSOLD and it is our opinion that the selling pressure that the stock has experienced is entirely due to broad market conditions and sentiment.\"  \n\n\"Based on this, we feel that BRM remains an extremely attractive VALUE stock.  As sentiment improves and the broad market stabilizes, we feel that BRM will return to its recent trading range of $1.00 to $1.50.\"\n\nA free copy of the report can be found at:  \nhttp://www.baystreet.ca/articles/research_reports/ccm_research/BRM_TechnicalReport_Mar_2%202009.pdf \n\nCCM Research is a division of Cronus Capital Markets, Inc.  Cronus Capital Markets, Inc., through its CCM Corporate Advisory division, entered into a one year C$55,0...

More updates from Biorem Inc.